Literature DB >> 12874301

Death pathways activated in CaCo-2 cells by Clostridium perfringens enterotoxin.

Ganes Chakrabarti1, Xin Zhou, Bruce A McClane.   

Abstract

Clostridium perfringens enterotoxin (CPE), a 35-kDa polypeptide, induces cytotoxic effects in the enterocyte-like CaCo-2 cell culture model. To identify the mammalian cell death pathway(s) mediating CPE-induced cell death, CaCo-2 cultures were treated with either 1 or 10 micro g of CPE per ml. Both CPE doses were found to induce morphological damage and DNA cleavage in CaCo-2 cells. The oncosis inhibitor glycine, but not a broad-spectrum caspase inhibitor, was able to transiently block both of those pathological effects in CaCo-2 cells treated with the higher, but not the lower, CPE dose. Conversely, a caspase 3/7 inhibitor (but not glycine or a caspase 1 inhibitor) blocked morphological damage and DNA cleavage in CaCo-2 cells treated with the lower, but not the higher, CPE dose. Collectively, these results indicate that lower CPE doses cause caspase 3/7-dependent apoptosis, while higher CPE doses induce oncosis. Apoptosis caused by the lower CPE dose was shown to proceed via a classical pathway involving mitochondrial membrane depolarization and cytochrome c release. As the CPE concentrations used in this study for demonstrating apoptosis and oncosis have pathophysiologic relevance, these results suggest that both oncosis and apoptosis may occur in the intestines during CPE-associated gastrointestinal disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12874301      PMCID: PMC166005          DOI: 10.1128/IAI.71.8.4260-4270.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

1.  Calcium-independent and dependent steps in action of Clostridium perfringens enterotoxin on HeLa and Vero cells.

Authors:  M Matsuda; N Sugimoto
Journal:  Biochem Biophys Res Commun       Date:  1979-11-28       Impact factor: 3.575

2.  Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization.

Authors:  E Bossy-Wetzel; D D Newmeyer; D R Green
Journal:  EMBO J       Date:  1998-01-02       Impact factor: 11.598

3.  Production, purification, and assay of Clostridium perfringens enterotoxin.

Authors:  J L McDonel; B A McClane
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

Review 4.  Defining apoptosis.

Authors:  D Hockenbery
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

5.  Molecular cloning of Porimin, a novel cell surface receptor mediating oncotic cell death.

Authors:  F Ma; C Zhang; K V Prasad; G J Freeman; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

6.  Evidence that alterations in small molecule permeability are involved in the Clostridium perfringens type A enterotoxin-induced inhibition of macromolecular synthesis in Vero cells.

Authors:  K I Hulkower; A P Wnek; B A McClane
Journal:  J Cell Physiol       Date:  1989-09       Impact factor: 6.384

7.  Internucleosomal cleavage of DNA as the sole criterion for apoptosis may be artifactual.

Authors:  H Enright; R P Hebbel; K A Nath
Journal:  J Lab Clin Med       Date:  1994-07

8.  Binding of Clostridium perfringens [125I]enterotoxin to rabbit intestinal cells.

Authors:  J L McDonel
Journal:  Biochemistry       Date:  1980-10-14       Impact factor: 3.162

9.  Protective effects of osmotic stabilizers on morphological and permeability alterations induced in Vero cells by Clostridium perfringens enterotoxin.

Authors:  B A McClane; J L McDonel
Journal:  Biochim Biophys Acta       Date:  1981-03-06

Review 10.  Apoptosis, oncosis, and necrosis. An overview of cell death.

Authors:  G Majno; I Joris
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

View more
  41 in total

1.  Regulation of Apoptosis by Gram-Positive Bacteria: Mechanistic Diversity and Consequences for Immunity.

Authors:  Glen C Ulett; Elisabeth E Adderson
Journal:  Curr Immunol Rev       Date:  2006-05

Review 2.  Comparative pathogenesis of enteric clostridial infections in humans and animals.

Authors:  Francisco A Uzal; Mauricio A Navarro; Jihong Li; John C Freedman; Archana Shrestha; Bruce A McClane
Journal:  Anaerobe       Date:  2018-06-05       Impact factor: 3.331

Review 3.  Intestinal barrier function: molecular regulation and disease pathogenesis.

Authors:  Katherine R Groschwitz; Simon P Hogan
Journal:  J Allergy Clin Immunol       Date:  2009-07       Impact factor: 10.793

4.  Noncytotoxic Clostridium perfringens enterotoxin (CPE) variants localize CPE intestinal binding and demonstrate a relationship between CPE-induced cytotoxicity and enterotoxicity.

Authors:  James G Smedley; Juliann Saputo; Jacquelyn C Parker; Mariano E Fernandez-Miyakawa; Susan L Robertson; Bruce A McClane; Francisco A Uzal
Journal:  Infect Immun       Date:  2008-05-27       Impact factor: 3.441

5.  Evidence that membrane rafts are not required for the action of Clostridium perfringens enterotoxin.

Authors:  Justin A Caserta; Martha L Hale; Michel R Popoff; Bradley G Stiles; Bruce A McClane
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

6.  Clostridium perfringens enterotoxin damages the human intestine in vitro.

Authors:  M E Fernández Miyakawa; V Pistone Creydt; F A Uzal; B A McClane; C Ibarra
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

7.  Identification of a claudin-4 residue important for mediating the host cell binding and action of Clostridium perfringens enterotoxin.

Authors:  Susan L Robertson; James G Smedley; Bruce A McClane
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

8.  A synthetic peptide corresponding to the extracellular loop 2 region of claudin-4 protects against Clostridium perfringens enterotoxin in vitro and in vivo.

Authors:  Archana Shrestha; Susan L Robertson; Jorge Garcia; Juliann Beingasser; Bruce A McClane; Francisco A Uzal
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

9.  Potential Therapeutic Effects of Mepacrine against Clostridium perfringens Enterotoxin in a Mouse Model of Enterotoxemia.

Authors:  Mauricio A Navarro; Archana Shrestha; John C Freedman; Juliann Beingesser; Bruce A McClane; Francisco A Uzal
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

10.  Synergistic effects of Clostridium perfringens enterotoxin and beta toxin in rabbit small intestinal loops.

Authors:  Menglin Ma; Abhijit Gurjar; James R Theoret; Jorge P Garcia; Juliann Beingesser; John C Freedman; Derek J Fisher; Bruce A McClane; Francisco A Uzal
Journal:  Infect Immun       Date:  2014-04-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.